Terms: = Uterine cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Clinical Outcome
19 results:
1. Deep Learning Based on MR Imaging for Predicting outcome of uterine Fibroid Embolization.
Luo YH; Xi IL; Wang R; Abdallah HO; Wu J; Vance AZ; Chang K; Kohi M; Jones L; Reddy S; Zhang ZS; Bai HX; Shlansky-Goldberg R
J Vasc Interv Radiol; 2020 Jun; 31(6):1010-1017.e3. PubMed ID: 32376183
[TBL] [Abstract] [Full Text] [Related]
2. GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study.
Brooks RA; Tritchler DS; Darcy KM; Lankes HA; Salani R; Sperduto P; Guntupalli S; DiSilvestro P; Kesterson J; Olawaiye AB; Moxley K; Waggoner S; Santin A; Rader JS; Kizer NT; Thaker PH; Powell MA; Mutch DG; Birrer MJ; Goodfellow PJ
Gynecol Oncol; 2019 May; 153(2):335-342. PubMed ID: 30827726
[TBL] [Abstract] [Full Text] [Related]
3. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria.
Snyder JE; Willett AB; Sun W; Kim Y
Pract Radiat Oncol; 2019 Mar; 9(2):e156-e163. PubMed ID: 30415074
[TBL] [Abstract] [Full Text] [Related]
4. Do fertile women have an inferior treatment for high-grade precancerous lesions?
Kim M; Cho HY; Lee J; Suh DH; Kim K; No JH; Kim YB
J Obstet Gynaecol Res; 2018 Apr; 44(4):772-777. PubMed ID: 29369475
[TBL] [Abstract] [Full Text] [Related]
5. Occult invasive cervical cancer after simple hysterectomy: a multi-center retrospective study of 89 cases.
Bai H; Cao D; Yuan F; Wang H; Chen J; Wang Y; Shen K; Zhang Z
BMC Cancer; 2016 Jul; 16():507. PubMed ID: 27439407
[TBL] [Abstract] [Full Text] [Related]
6. A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Bender D; Sill MW; Lankes HA; Reyes HD; Darus CJ; Delmore JE; Rotmensch J; Gray HJ; Mannel RS; Schilder JM; Hunter MI; McCourt CK; Samuelson MI; Leslie KK
Gynecol Oncol; 2015 Sep; 138(3):507-12. PubMed ID: 26186911
[TBL] [Abstract] [Full Text] [Related]
7. Architectural versus nuclear atypia-defined FIGO grade 2 endometrial endometrioid adenocarcinoma (EEC): a clinicopathologic comparison of 154 cases with clinical follow-up.
Winham WM; Lin D; Stone PJ; Nucci MR; Quick CM
Int J Gynecol Pathol; 2014 Mar; 33(2):120-6. PubMed ID: 24487465
[TBL] [Abstract] [Full Text] [Related]
8. Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases.
Schoolmeester JK; Howitt BE; Hirsch MS; Dal Cin P; Quade BJ; Nucci MR
Am J Surg Pathol; 2014 Feb; 38(2):176-88. PubMed ID: 24418852
[TBL] [Abstract] [Full Text] [Related]
9. Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis.
Diaz-Padilla I; Romero N; Amir E; Matias-Guiu X; Vilar E; Muggia F; Garcia-Donas J
Crit Rev Oncol Hematol; 2013 Oct; 88(1):154-67. PubMed ID: 23562498
[TBL] [Abstract] [Full Text] [Related]
10. A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: a Gynecologic Oncology Group study.
McMeekin DS; Sill MW; Darcy KM; Abulafia O; Hanjani P; Pearl ML; Rubin SC; Rose PG; Small L; Benbrook DM
Gynecol Oncol; 2012 Nov; 127(2):356-61. PubMed ID: 22796461
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
[TBL] [Abstract] [Full Text] [Related]
12. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
Manavi M; Hudelist G; Fink-Retter A; Gschwandtler-Kaulich D; Pischinger K; Czerwenka K
Gynecol Oncol; 2007 May; 105(2):418-26. PubMed ID: 17306351
[TBL] [Abstract] [Full Text] [Related]
13. Tumor hypoxia and expression of c-met in cervical cancer.
Leo C; Horn LC; Einenkel J; Hentschel B; Höckel M
Gynecol Oncol; 2007 Jan; 104(1):181-5. PubMed ID: 16996116
[TBL] [Abstract] [Full Text] [Related]
14. cDNA array analysis of cytobrush-collected normal and malignant cervical epithelial cells: a feasibility study.
Hudelist G; Czerwenka K; Singer C; Pischinger K; Kubista E; Manavi M
Cancer Genet Cytogenet; 2005 Apr; 158(1):35-42. PubMed ID: 15771902
[TBL] [Abstract] [Full Text] [Related]
15. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
Giuntoli RL; Metzinger DS; DiMarco CS; Cha SS; Sloan JA; Keeney GL; Gostout BS
Gynecol Oncol; 2003 Jun; 89(3):460-9. PubMed ID: 12798712
[TBL] [Abstract] [Full Text] [Related]
16. Overexpression of the c-met/HGF receptor and its prognostic significance in uterine cervix carcinomas.
Baykal C; Ayhan A; Al A; Yüce K; Ayhan A
Gynecol Oncol; 2003 Feb; 88(2):123-9. PubMed ID: 12586590
[TBL] [Abstract] [Full Text] [Related]
17. Predictors of outcome in small cell carcinoma of the cervix--a case series.
Straughn JM; Richter HE; Conner MG; Meleth S; Barnes MN
Gynecol Oncol; 2001 Nov; 83(2):216-20. PubMed ID: 11606074
[TBL] [Abstract] [Full Text] [Related]
18. Cervical cancer and sexual lifestyle: a systematic review of health education interventions targeted at women.
Shepherd J; Peersman G; Weston R; Napuli I
Health Educ Res; 2000 Dec; 15(6):681-94. PubMed ID: 11142076
[TBL] [Abstract] [Full Text] [Related]
19. Interventions for encouraging sexual lifestyles and behaviours intended to prevent cervical cancer.
Shepherd J; Weston R; Peersman G; Napuli IZ
Cochrane Database Syst Rev; 2000; (2):CD001035. PubMed ID: 10796735
[TBL] [Abstract] [Full Text] [Related]